Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models

Journal of Cellular Biochemistry

Volumn 116, Issue 12, 2015, Pages 2956-2969

  Lutful Kabir, Farruk Mohammad ^a   DeInnocentes, Patricia ^a   Bird, Richard Curtis ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

BREAST CANCER; CANINE CANCER MODEL; CYCLIN DEPENDENT KINASE INHIBITOR; INK4A; miRNA; TUMOR SUPPRESSOR

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MICRORNA; MICRORNA 1; MICRORNA 140; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 155; MICRORNA 190A; MICRORNA 199; MICRORNA 203; MICRORNA 206; MICRORNA 21; MICRORNA 214; MICRORNA 31; MICRORNA 376A; MICRORNA 432; MICRORNA 9; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; TRANSCRIPTOME;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER MODEL; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN RNA BINDING; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; DISEASE MODEL; DOG; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOLECULARLY TARGETED THERAPY; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; TRANSCRIPTOME;

EID: 84943568580     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25243     Document Type: Article

References (44)

1. Anastasi S, Sala G, Huiping C, Caprini E, Russo G, Iacovelli S, Lucini F, Ingvarsson S, Segatto O,. 2005. Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 24: 4540-4548.
2. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM,. 2004. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760.
3. Croce CM, Calin GA,. 2005. MiRNAs, cancer, and stem cell division. Cell 122: 6-7.
4. DeInnocentes P, Agarwal P, Bird RC,. 2009. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer. J Cell Biochem 106: 491-505.
5. Fabian MR, Sonenberg N, Filipowicz W,. 2010. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
6. Friedman RC, Farh KK, Burge CB, Bartel DP,. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
7. Garzon R, Calin GA, Croce CM,. 2009. MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
8. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP,. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27: 91-105.
9. Harquail J, Benzina S, Robichaud GA,. 2012. MicroRNAs and breast cancer malignancy: An overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark 11: 269-280.
10. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM,. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, 3rd, Johnson BE, Skolnick MH,. 1994a. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
12. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, et al., 1994b. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 23-26.
13. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, Harte RA, Heitner S, Hinrichs AS, Learned K, Lee BT, Li CH, Raney BJ, Rhead B, Rosenbloom KR, Sloan CA, Speir ML, Zweig AS, Haussler D, Kuhn RM, Kent WJ,. 2014. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 42: D764-D770.
14. Klopfleisch R, Gruber AD,. 2009. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. Res Vet Sci 87: 91-96.
15. Klopfleisch R, Lenze D, Hummel M, Gruber AD,. 2010. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 10: 618.
16. Korbie DJ, Mattick JS,. 2008. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat Protoc 3: 1452-1456.
17. Kozomara A, Griffiths-Jones S,. 2014. MiRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42: D68-D73.
18. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T,. 2001. Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
19. Laurila EM, Kallioniemi A,. 2013. The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer 52: 1103-1113.
20. Lewis BP, Burge CB, Bartel DP,. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
21. Li L, Yuan L, Luo J, Gao J, Guo J, Xie X,. 2013. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 13: 109-117.
22. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X,. 2008. MiR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404.
23. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR,. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
24. Lutful Kabir FM, Agarwal P, Deinnocentes P, Zaman J, Bird AC, Bird RC,. 2013. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus. J Cell Biochem 114: 56-66.
25. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA,. 2010. MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
26. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D,. 1995. A novel p16INK4A transcript. Cancer Res 55: 2995-2997.
27. Reczko M, Maragkakis M, Alexiou P, Papadopoulos GL, Hatzigeorgiou AG,. 2011. Accurate microRNA target prediction using detailed binding site accessibility and machine learning on proteomics data. Front Genet 2: 103.
28. Rovira C, Guida MC, Cayota A,. 2010. MicroRNAs and other small silencing RNAs in cancer. IUBMB Life 62: 859-868.
29. Ruas M, Peters G,. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378: F115-F177.
30. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB,. 2008. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320: 1643-1647.
31. Schickel R, Boyerinas B, Park SM, Peter ME,. 2008. MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974.
32. Sharpless NE., 2005. INK4a/ARF: A multifunctional tumor suppressor locus. Mutat Res 576: 22-38.
33. Shrout TA., 2013. Post-transcriptional regulation of cardiac sarcomere protein titin through 3′untranslated regions. Vanderbilt Undergrad Res J 9: 1-12.
34. Stefani G, Slack FJ,. 2008. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
35. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A,. 1995. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55: 2988-2994.
36. Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, Marconato L, Abramo F, Ciliberto G, Lahm A, La Monica N, de Rinaldis E,. 2009. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 10: 135.
37. Vail DM, MacEwen EG,. 2000. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18: 781-792.
38. Wang Y, Blelloch R,. 2009. Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res 69: 4093-4096.
39. Wolfe LG, Oliver JL, Smith BB, Toivio-Kinnucan MA, Powers RD, Brawner WR, Henderson RA, Hankes GH,. 1987. Biologic characterization of canine melanoma cell lines. Am J Vet Res 48: 1642-1648.
40. Wolfe LG, Smith BB, Toivio-Kinnucan MA, Sartin EA, Kwapien RP, Henderson RA, Barnes S,. 1986. Biologic properties of cell lines derived from canine mammary carcinomas. J Natl Cancer Inst 77: 783-792.
41. You J, Bird RC,. 1995. Selective induction of cell cycle regulatory genes cdk1 (p34cdc2), cyclins A/B, and the tumor suppressor gene Rb in transformed cells by okadaic acid. J Cell Physiol 164: 424-433.
42. Zhang CM, Zhao J, Deng HY,. 2013. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci 20: 79.
43. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J,. 2007a. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-744.
44. Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, Resau J, Sigler R, Bronson R, Vande Woude GF,. 2007b. Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 26: 269-276.